îæ€çŽ¢
îæ€çŽ¢
î
SAB Biotherapeutics Inc
SABSîãŠã©ãããªã¹ãã«è¿œå
3.350USD
-0.040-1.18%
çµå€Â 09-24 16:00ïŒETïŒ
256.14Mæ䟡ç·é¡
7.83çŽè¿12ã¶æPER
æ ªäž»
æŽæ°æå»: Sun, May 10
æŽæ°æå»: Sun, May 10
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Vivo Capital, LLC
14.94%
Commodore Capital LP
5.76%
RA Capital Management, LP
5.76%
Perceptive Advisors LLC
4.54%
Millennium Management LLC
4.49%
ä»ã®
64.52%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Vivo Capital, LLC
14.94%
Commodore Capital LP
5.76%
RA Capital Management, LP
5.76%
Perceptive Advisors LLC
4.54%
Millennium Management LLC
4.49%
ä»ã®
64.52%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Venture Capital
31.42%
Hedge Fund
27.19%
Investment Advisor
12.26%
Private Equity
6.81%
Investment Advisor/Hedge Fund
6.54%
Research Firm
1.96%
Individual Investor
1.16%
Corporation
0.11%
Family Office
0.10%
ä»ã®
12.46%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Apr 1
æŽæ°æå»: Wed, Apr 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
84
42.73M
84.08%
+12.30M
2025Q4
69
29.75M
62.49%
+26.05M
2025Q3
63
8.42M
80.88%
+5.01M
2025Q2
77
3.86M
41.43%
-1.53M
2025Q1
83
4.42M
47.57%
-1.24M
2024Q4
84
4.36M
47.19%
-1.19M
2024Q3
92
4.88M
52.85%
-650.39K
2024Q2
94
4.85M
52.54%
-723.93K
2024Q1
99
5.12M
55.54%
-327.29K
2023Q4
101
5.29M
57.38%
+3.28M
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Vivo Capital, LLC
11.42M
17.06%
--
--
Dec 31, 2025
Commodore Capital LP
4.40M
6.58%
--
--
Dec 31, 2025
RA Capital Management, LP
4.40M
6.58%
--
--
Mar 19, 2026
Perceptive Advisors LLC
3.47M
5.19%
+2.67M
+332.25%
Jan 14, 2026
Millennium Management LLC
324.09K
0.48%
+324.09K
--
Dec 31, 2025
Woodline Partners LP
2.85M
4.26%
--
--
Dec 31, 2025
Spruce Street Capital LP
2.20M
3.28%
+2.20M
--
Dec 31, 2025
Sessa Capital
2.20M
3.28%
--
--
Mar 02, 2026
Blackstone Alternative Asset Management, L.P.
2.14M
3.2%
+2.14M
--
Dec 31, 2025
詳现ãèŠã
ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
Simplify Propel Opportunities ETF
0.81%
iShares Micro-Cap ETF
0%
Simplify Propel Opportunities ETF
æ¯ç0.81%
iShares Micro-Cap ETF
æ¯ç0%